Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.
Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T. Murata M, et al. Among authors: atsuta y. Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21. Bone Marrow Transplant. 2017. PMID: 27869808 Clinical Trial.
Allogeneic myeloablative transplantation for patients aged 50 years and over.
Yanada M, Emi N, Naoe T, Sakamaki H, Iseki T, Hirabayashi N, Karasuno T, Chiba S, Atsuta Y, Hamajima N, Takahashi S, Kato S. Yanada M, et al. Among authors: atsuta y. Bone Marrow Transplant. 2004 Jul;34(1):29-35. doi: 10.1038/sj.bmt.1704518. Bone Marrow Transplant. 2004. PMID: 15156161
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N, Hiraoka A, Kanda Y, Tanosaki R, Okamoto S, Iwato K, Atsuta Y, Hamajima N, Tanimoto M, Kato S. Yanada M, et al. Among authors: atsuta y. Bone Marrow Transplant. 2004 Aug;34(4):331-7. doi: 10.1038/sj.bmt.1704596. Bone Marrow Transplant. 2004. PMID: 15220958
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
Yanada M, Naoe T, Iida H, Sakamaki H, Sakura T, Kanamori H, Kodera Y, Okamoto S, Kanda Y, Sao H, Asai O, Nakai K, Maruta A, Kishi K, Furukawa T, Atsuta Y, Yamamoto K, Tanaka J, Takahashi S. Yanada M, et al. Among authors: atsuta y. Bone Marrow Transplant. 2005 Nov;36(10):867-72. doi: 10.1038/sj.bmt.1705148. Bone Marrow Transplant. 2005. PMID: 16113659
Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group.
Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AK, Liang R, Chan LL, Haipeng L, Tan PL, Hwang WY, Chiou TJ, Chen PM, Van Binh T, Minh NN, Min CK, Hwang TJ, Kodera Y; Asia-Pacific Blood and Marrow Transplantation Group (APBMT). Yoshimi A, et al. Among authors: atsuta y. Bone Marrow Transplant. 2010 Dec;45(12):1682-91. doi: 10.1038/bmt.2010.34. Epub 2010 Mar 1. Bone Marrow Transplant. 2010. PMID: 20190847
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.
Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H, Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R. Mizuta S, et al. Among authors: atsuta y. Leukemia. 2011 Jan;25(1):41-7. doi: 10.1038/leu.2010.228. Epub 2010 Oct 14. Leukemia. 2011. PMID: 20944676
724 results